E-mail: info@psoriasisaustralia.org.au    |

Upcoming event

Join us on World Psoriasis Day – Thursday October 29 – for a live virtual event.  We will be hosting a panel discussion with dermatologist Dr Rebecca Nguyen, rheumatologist Dr Irwin Lim and one of our psoriasis community, Sarah Ridsdale.

Bring along your questions, or share them in advance and join us to Be Informed.

The fine print: the panel discussion will run for around 20 minutes followed by a Q&A session for around 10 minutes. Joining guests will be muted and questions can be posted in the chat function of the platform. Click here from 7.20pm for a 7.30pm AEST start.

This event is supported by Novartis.


Who we are

Psoriasis Australia is the only Australian patient support group registered with IFPA, the International Federation of Psoriasis Associations, and IADPO (Global Skin) the International Association of Dermatology Patients Organisations. As part of a larger global federation, we have the power to mobilize psoriasis stakeholders from a wide range of countries and sectors. bringing together people with psoriasis, healthcare professionals, leading experts and industry partners through events like the World Psoriasis & Psoriatic Arthritis Conference and the annual World Psoriasis Day.

We strive to assist people with Psoriasis, and Psoriatic Arthritis, ( or those just wanting to know about psoriasis ), by providing up to date information and support enabling educated decisions to be made on treatment choices and lifestyle changes.

The Impact of Psoriasis

1.6 million

Australians suffer

More than a skin disease

diabetes, cardiovascular disease, Crohn’s disease, depression, Metabolic syndrome, Psoriatic arthritis

Donate to Psoriasis Australia today

Upcoming Events

Latest News

Targeting much more than ‘influenza of the skin’ – New biologic for chronic plaque psoriasis set to be PBS listed

A new targeted biologic for the estimated 19,000 Australian adults living with severe chronic plaque psoriasis1 will be listed on the Pharmaceutical Benefits Scheme (PBS) on February 1, 2019 for those who meet the reimbursement criteria. ILUMYA™ (tildrakizumab) belongs to a new class of biologic medicines, known as interleukin (IL) inhibitors, that specifically block a…

January 27, 2019
Medicines for the treatment of psoriasis listed on the PBS

The Liberal National Government will make two new medicines for the treatment of the skin condition psoriasis more affordable, saving patients up to $32,600 per year. The medicine Tremfya® (Guselkumab) is being listed on the Pharmaceutical Benefits Scheme (PBS) from February 1 for the treatment of severe chronic plaque psoriasis. The medicine would cost around…

January 27, 2019

You may find that psoriasis affects not only your skin, but how you feel and your quality of life. It’s important to remember that psoriasis isn’t something you have to go through alone.   The Get Psorted Get Connected peer support program connects you with a trained peer supporter who understands what it’s like to…

August 2, 2018
No Comments

Member of